title: Lipiodol retention within hepatic cavernous hemangioma.
abstract: Intraarterial injection of Lipiodol has been recommended to differentiate hepatocellular carcinoma from benign lesions such as cavernous hemangioma, because uptake and prolonged retention of the contrast medium is a characteristic of the malignant tumors. In two cases of cavernous hemangioma of the liver in which we injected Lipiodol, uptake and retention up to 3 months was demonstrated. We conclude that the intraarterial injection of Lipiodol may not be reliable in differentiating hepatocellular carcinoma from cavernous hemangioma of the liver.
authors.affiliation: Med-Imagem, Hospital Beneficêncía Portuguesa, São Paulo, Brazil.
authors.forename: R
authors.initials: R
authors.lastname: Uflacker
authors.forename: G S
authors.initials: GS
authors.lastname: Mourão
authors.forename: R L
authors.initials: RL
authors.lastname: Piske
mesh_terms: D000328:Adult; D000792:Angiography; D005260:Female; D006392:Hemangioma, Cavernous / Q000000981:diagnostic imaging / Q000378:metabolism*; D006801:Humans; D007269:Injections, Intra-Arterial; D007459:Iodized Oil / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014057:Tomography, X-Ray Computed
chemical_list: D007459:Iodized Oil